神经科学
药物靶点
药物开发
疾病
脑病
药品
医学
心理学
药理学
病理
作者
Che-Wei Chang,Qiang Shao,Lennart Mucke
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2021-02-25
卷期号:371 (6532)
被引量:245
标识
DOI:10.1126/science.abb8255
摘要
Several lines of evidence implicate the protein tau in the pathogenesis of multiple brain disorders, including Alzheimer's disease, other neurodegenerative conditions, autism, and epilepsy. Tau is abundant in neurons and interacts with microtubules, but its main functions in the brain remain to be defined. These functions may involve the regulation of signaling pathways relevant to diverse biological processes. Informative disease models have revealed a plethora of abnormal tau species and mechanisms that might contribute to neuronal dysfunction and loss, but the relative importance of their respective contributions is uncertain. This knowledge gap poses major obstacles to the development of truly impactful therapeutic strategies. The current expansion and intensification of efforts to translate mechanistic insights into tau-related therapeutics should address this issue and could deliver better treatments for a host of devastating conditions.
科研通智能强力驱动
Strongly Powered by AbleSci AI